Wiskott-Aldrich Syndrome

This is a very rare condition that only affects boys. It's a type of immune system problem where the body doesn't fight off infections well. It also causes skin rashes (eczema) and low blood cell counts. Doctors often see low levels of certain antibodies and high levels of others.

Condition

What people with Wiskott-Aldrich Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Wiskott-Aldrich Syndrome?

NameHow it went

About Wiskott-Aldrich Syndrome

What It Is

Wiskott-Aldrich syndrome (WAS) is a rare inherited condition that affects both the blood and the immune system. It is caused by a missing or faulty protein that blood cells need in order to move, attach to other cells and respond to threats. As a result, platelets (the cells that help blood clot) are too few and unusually small, and white blood cells do a poor job of fighting infection. In its classic form, WAS combines three problems: easy bleeding and bruising, frequent or severe infections, and eczema, an itchy, inflamed skin rash. People with WAS also have a higher chance of autoimmune disease, in which the immune system attacks the body's own tissues, and of cancers of the immune cells, especially lymphoma. Severity varies widely. Some people mainly have low platelets, a milder pattern known as X-linked thrombocytopenia (low platelet count). Specialists now caution that even these milder forms can lead to serious autoimmune problems and cancer.

Causes & Risk Factors

WAS is caused by a change (variant) in the WAS gene, which carries the instructions for a protein called the Wiskott-Aldrich syndrome protein (WASP). The gene sits on the X chromosome. Boys have only one X chromosome, so a single altered copy is enough to cause the condition, which is why WAS almost always affects boys. Girls and women who carry one altered copy usually have few or no symptoms, although some have milder features. It is estimated to affect between 1 and 10 in every million boys. An affected boy may have brothers or uncles on his mother's side with the same condition, but about one in three has no family history because the gene change arose new. The specific variant helps predict severity: variants that leave almost no working WASP usually cause the classic form, while those that allow some protein tend to cause milder disease. People with the same variant can still differ. Nothing a parent did during pregnancy or afterward causes WAS.

How It's Diagnosed

WAS is usually suspected in a baby or young boy with unusual bruising or bleeding, tiny red-purple spots on the skin (petechiae) or bloody stools, often together with eczema or repeated infections. A routine blood count gives the first clue. Platelets are low and, unlike in most other causes of a low platelet count, they are also smaller than normal, which shows up as a low mean platelet volume on the report. Because low platelets can look like immune thrombocytopenia (ITP), a more common condition in which antibodies destroy platelets, WAS is sometimes mistaken for ITP at first. The diagnosis is confirmed by genetic testing of the WAS gene and by a specialized blood test that measures how much WASP the blood cells make. Immune testing often shows weak antibody responses to some vaccines and high levels of IgE, an antibody linked to allergy. Identifying the exact variant helps predict how severe the condition is likely to be, and it allows testing of female relatives who may be carriers and testing in a future pregnancy.

Treatment Options

Treatment has two aims: protecting against bleeding and infection now, and, for most people, replacing the faulty blood-forming system with one that works. Specialists now recommend offering most young children a potentially curative treatment soon after diagnosis, because results are best when it is done early and before severe infections occur. Some older people with milder variants are instead followed closely with supportive care. A hematopoietic stem cell transplant (often called a bone marrow transplant) replaces the person's blood-forming stem cells with a donor's. It requires chemotherapy beforehand to make room for the new cells and prevent rejection, and it carries a risk of graft-versus-host disease, in which the donor's immune cells attack the body. Results are best with a fully matched brother or sister as donor. In a large North American study, about 87% of people were alive five years after transplant, and survival was lower when the transplant took place at age 5 or older or after a severe infection. Gene therapy is an option for people 6 months and older who would benefit from a transplant but have no suitably matched related donor. Waskyra (etuvetidigene autotemcel), approved in the US in December 2025, uses the person's own stem cells, collected from the blood, with a working copy of the WAS gene added in a laboratory. Because the cells are the person's own, graft-versus-host disease is not a risk. In the 27 people studied for the approval, severe infections fell by more than 90% in the period from 6 to 18 months after treatment, compared with the year before treatment. Moderate or severe bleeding fell by about 60% in the first year after treatment. The trade-offs are real: chemotherapy is still needed before the infusion, blood counts stay very low for several weeks, serious infections can occur, and because the new gene is delivered by a modified virus, there is a lifelong risk of a treatment-related cancer that requires ongoing monitoring. Before curative treatment, or when it is not chosen, supportive care lowers day-to-day risk. Most people receive immunoglobulin replacement, antibodies collected from donated plasma and given into a vein or under the skin, and many take preventive antibiotics. Live vaccines, such as rotavirus, MMR (measles, mumps and rubella) and chickenpox, must be avoided because the weakened vaccine virus can cause infection; other vaccines are safe but may not protect fully. Platelet transfusions are used to treat serious bleeding rather than to prevent it, because their effect is short-lived, and iron is often needed to replace ongoing blood loss. Eczema usually needs a thick moisturizing ointment at least twice a day and steroid ointments for flares. Autoimmune complications may be treated with steroids such as prednisone or with rituximab, a medicine that removes antibody-producing B cells. Removing the spleen (splenectomy) can raise the platelet count, but it does not fix the immune problems and makes overwhelming bloodstream infections far more likely. Anyone without a spleen needs daily preventive antibiotics for life, so the operation is now reserved for selected people with severe, dangerous bleeding.

What to Expect

WAS is lifelong unless it is corrected with a transplant or gene therapy, and its course varies a great deal between people. A few decades ago, most children with classic WAS did not survive early childhood. Better infection prevention and immunoglobulin, and above all earlier transplant and gene therapy, have changed that outlook, and many children who receive curative treatment go on to attend school and take part in sports and ordinary activities. Before correction, daily life centers on lowering bleeding and infection risk: regular immunoglobulin treatments, daily skin care, close attention to fevers and protecting young children from head injuries. Bleeding into the brain is the most dangerous complication and happens mostly in the first years of life, so some clinicians recommend a protective helmet for toddlers. Food allergies are common, and an allergist may prescribe an epinephrine auto-injector. Care is usually led by an immunologist at a specialist center, working with hematology, dermatology and transplant teams. Follow-up continues after curative treatment: people take medicines to prevent graft-versus-host disease for a period after a transplant, and after gene therapy they are monitored long term for blood cancers. Without curative treatment, the risk of lymphoma and other cancers rises with age, which is one reason specialists favor treating early. Genetic counseling can help families understand who else may carry the variant and what it means for future pregnancies.

When to Seek Help

Ask a doctor about a possible bleeding or immune disorder if a baby or young boy has unexplained bruising, tiny red-purple spots on the skin, bloody stools, or eczema together with frequent infections, especially if a male relative has had similar problems or low platelets. For someone with WAS, call the care team promptly about signs of infection or after contact with someone who has chickenpox, since early treatment can prevent complications. Seek emergency care for bleeding that does not stop with usual measures such as firm pressure. Also seek emergency care after any significant blow to the head, or for signs of possible bleeding in the brain even without a known injury: unusual sleepiness, repeated vomiting, a severe headache, a seizure or new weakness. In anyone whose spleen has been removed, a fever alone is an emergency, because infections without a spleen can become life-threatening quickly. If someone with a known food allergy has a severe allergic reaction, use the prescribed epinephrine and call 911.

Questions to Ask Your Doctor

  1. 1.Which WAS variant has been found, and what does it suggest about how severe the condition is likely to be?
  2. 2.Is a stem cell transplant or gene therapy right for us, and how do the timing, donor options and risks compare?
  3. 3.Until then, what is our plan for fevers, bleeding and head injuries, and who do we call after hours?
  4. 4.Which vaccines should be given, and which must be avoided?
  5. 5.Should the mother, sisters or other relatives be tested to see whether they carry the variant?

Last reviewed • Oct 2026

Educational content, not medical advice.